Company intelligence / Profile preview

MaNaDr

Ownership: Private
Employees: ~58
Development stage: Other

Overview

The company operates a commercial-stage global telehealth ecosystem with advanced AI-driven features. It has expanded into Indonesia through the acquisition of Lifepack and continues to roll out new services such as AI-powered medical scribing and at-home dental scans. The company reports positive operational milestones post-H1 FY2025 with expectations to achieve profitability before H1 FY2027.

Therapeutic areas: Metabolic DisordersEndocrinologyOther
Modalities: Device (telehealth platform)AI-powered healthcare solutions
Industry: Non-Academic Healthcare

Partnerships

Collaborated with over 1,500 healthcare professionals in Singapore including GPs, specialists & allied providers

Beyond the preview

Go deeper on MaNaDr.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MaNaDr.

Explore the full profile